Notice of Intent to Publish a Funding Opportunity Announcement for Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C Clinical Trial Not Allowed).
Notice Number:

Key Dates

Release Date:
April 27, 2022
Estimated Publication Date of Funding Opportunity Announcement:
June 13, 2022
First Estimated Application Due Date:
October 26, 2022
Earliest Estimated Award Date:
July 01, 2023
Earliest Estimated Start Date:
July 01, 2023
Related Announcements


Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to invite applications for an initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 2 diabetes research (SEIC-T2D).

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. 

The FOA is expected to be published in late Spring 2022 with an expected application due date in Fall of 2022.

This FOA will utilize the U2C activity code. Details of the planned FOA are provided below.

Research Initiative Details

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has initiated new efforts to address health disparities and advance health equity. A fundamental equity approach involves meaningful inclusion of individuals from and communities of diverse backgrounds and sectors in developing the research priorities and activities that involve them, particularly NIH designated health disparities populations, historically marginalized populations, and those with the highest proportion of diabetes-related morbidity and mortality. Research evidence indicates that stakeholder engagement that involves trust building, use of culturally appropriate research designs, questions, and materials (i.e., outreach, recruitment, informed consents), can result in powerful outcomes such as achievement of recruitment and retention milestones, and improved uptake and sustainability of successful interventions beyond the funded project period. Examples of methods used to enhance stakeholder engagement include person-centered approaches such as design consultancy models and community engagement studios that involve customized community input sessions focused on specific cores or all aspects of a research project. The opportunity to advance type 2 diabetes (T2D) treatment and prevention with effective interventions that have potential for uptake by communities experiencing health disparities and health inequities is necessary to make sustained progress in promoting health equity. 

To address this need, the planned FOA will establish a novel national Stakeholder Engagement Innovation Center for advancing equity in T2D research (SEIC-T2D). A primary goal of the SEIC-T2D is to accelerate equitable engagement of stakeholders representing diverse backgrounds and sectors in T2D research, particularly those with experience collaborating with culturally and linguistically diverse communities that experience diabetes-related health disparities, and systems that impact their health. The SEIC-T2D will provide highly specialized research resources to support investigators by fully embedding communities, patients, and other stakeholders into the full spectrum of research activities through expert consultations and education in principles and methods of community-engaged research. The SEIC-T2D will also establish a network consisting of , multidisciplinary research investigators, including from underrepresented groups, with expertise in T2D and community-engaged methods, community experts with lived experiences, and representatives of various health and other organizations deemed essential for addressing disparities and advancing health equity in T2D prevention and treatment. 

This Notice encourages investigators with expertise and insights into this area of advancing health equity, community-engaged/-based participatory research, pragmatic clinical trials and implementation science to begin to consider working with their relevant institutions to apply for this new FOA. The SEIC-T2D will initiate and build a robust infrastructure for delivering expert research engagement resources to improve uptake of appropriate research principles and methods to improve equity, and stakeholder engagement in developing research studies, and in mitigating obstacles with research studies that are not meeting proposed targets (e.g., challenges with delayed recruitment and retention, insufficient participatory research methods). Since a very limited number of awards will be made, each applicant will be expected to leverage existing partnerships and establish new ones, as needed during the award, across U.S. geographic regions with communities and organizations representing populations at risk for or living with T2D, especially underserved communities and those with diabetes-related health disparities.

Funding Information


Estimated Total Funding


Expected Number of Awards
Estimated Award Ceiling


Primary Assistance Listing Number(s)


Anticipated Eligible Organizations
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Regional Organization
Eligible Agencies of the Federal Government

Applications are not being solicited at this time. 


Please direct all inquiries to:

Beena Akolkar, Ph.D. 

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Shavon Artis Dickerson, Dr.P.H., M.P.H.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-435-3055